ACETO Board of Directors Declares Quarterly Cash Dividend
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
- Nebius shares sink on CoreWeave's bond yield spike and insider sales
- IonQ prices $2 billion equity offering at $40 per share
- Rocket Lab delays Neutron rocket debut to 2027
- Bloom Energy stock falls as inflation data pressures markets
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
ACETO Corp (ACET) Announces U.S. Launch of Generic Patanol
December 7, 2015 2:45 PM ESTACETO Corporation (NASDAQ: ACET) announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, is launching Olopatadine Hydrochloride 0.1% Ophthalmic Solution, an FDA-approved generic version of Alcon Inc.'s Patanol.
According to IMS Health data, U.S. market sales for Olopatadine Hydrochloride... More
ACETO Corp (ACET) Declares $0.06 Quarterly Dividend; 0.9% Yield
December 3, 2015 2:55 PM ESTACETO Corp (NASDAQ: ACET) declared a quarterly dividend of $0.06 per share, or $0.24 annualized.
The dividend will be payable on December 28, 2015, to stockholders of record on December 17, 2015, with an ex-dividend date of December 15, 2015.
The annual yield on the dividend is 0.9... More



